Solid organ allograft recipients may require large amounts of blood components. The modification of components to make them safer for iatrogenically immunosuppressed transplant patients increases workload demands on blood banks and transfusion services.
Institutions within the United States and Canada providing hemotherapy as support for transplant recipients were surveyed for their transfusion practices.
Responses from 25 institutions provide the data for this report. In 1991, the mean intraoperative red cell requirements ranged from